Claudia Vergelli

8PUBLICATIONS
24CO-AUTHORS
Cheminformatics and quantitative structure-activity relationshipsMolecular targetsBiomolecular modelling and designBiologically active moleculesPharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Feb 27, 2026
Discovery of Potent PDE4 Inhibitors with 3(2H)-Pyridazinone Scaffold: Synthesis, In Silico Studies and In Vitro/Vivo Evaluation.

Claudia Vergelli, Letizia Crocetti, Gabriella Guerrini

|Jul 30, 2023
Optimization of 4-amino-pyridazin-3(2H)-one as a valid core scaffold for FABP4 inhibitors.

Giuseppe Floresta, Letizia Crocetti, Renan Rodrigues de Oliveira Silva

|Jun 28, 2023
Protective and Pain-Killer Effects of AMC3, a Novel N-Formyl Peptide Receptors (FPRs) Modulator, in Experimental Models of Rheumatoid Arthritis.

Valentina Ferrara, Alessandra Toti, Elena Lucarini

|Apr 13, 2023
4,5-Dihydro-5-Oxo-Pyrazolo[1,5-a]Thieno[2,3-c]Pyrimidine: A Novel Scaffold Containing Thiophene Ring. Chemical Reactivity and In Silico Studies to Predict the Profile to GABAA Receptor Subtype.

Letizia Crocetti, Gabriella Guerrini, Fabrizio Melani

|Nov 11, 2022
GABAA Receptor Modulators with a Pyrazolo[1,5-a]quinazoline Core: Synthesis, Molecular Modelling Studies and Electrophysiological Assays.

Letizia Crocetti, Gabriella Guerrini, Fabrizio Melani

|Nov 10, 2022
Ligand Growing Experiments Suggested 4-amino and 4-ureido pyridazin-3(2H)-one as Novel Scaffold for FABP4 Inhibition.

Letizia Crocetti, Giuseppe Floresta, Chiara Zagni

Pageof 2

Frequent Collaborators

7 joint publications

Letizia Crocetti

5 joint publications

Gabriella Guerrini

2 joint publications

Maria Paola Giovannoni

2 joint publications

Mark T Quinn